4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
AtaiBeckley Inc. (ATAI) operates in the Biotechnology industry and is headquartered in New York, United States with about 99 employees. Its market capitalization is roughly $3 billion. In the fiscal year ended 2025-12-31, ATAI reported $4M in revenue and ($660M) in net income.
AtaiBeckley Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada.
Interactive charts & full statements → Open the ATAI valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $4M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($113M) | ($102M) | ($123M) | ($144M) | — |
| Net Income | ($660M) | ($149M) | ($40M) | ($152M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $1M | $1M | $1M | $1M | $2M | — |
| Operating Income (EBIT) | ($30M) | ($39M) | ($28M) | ($25M) | ($20M) | — |
| Net Income | ($30M) | ($545M) | ($61M) | ($28M) | ($26M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $293M | $159M | $294M | $305M | — |
| Total Liabilities | $71M | $43M | $49M | $40M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ATAI viewer.
About TickerBase · Data methodology & sources